In our study, attenuated miR-214 expression resulting from genomic loss or other mechanisms coupled with increased PDRG1 level may provide new prognostic biomarkers for the intervention of bladder cancer. This evidence concerns the gene PDRG1 and urinary bladder carcinoma.